Skip to content
Get BIO’s view on everything from health care to biofuels and the bioeconomy. The below articles include BIO statements, opinion, and calls to action, as well as articles and op-eds written by BIO leadership.
With the partnering system to arrange face-to-face meetings at the BIO International Convention filling up at a record pace, anyone who wants to do […]
BIO International Convention partnering is moving at a record pace Read More »
Discovered only about a decade ago, CRISPR Cas-9 enables rapid development of exciting new treatments—and more breakthroughs are on the way, today’s new episode of
I am BIO Podcast: CRISPR revolution just starting Read More »
On Friday, U.S. District Judge Matthew Kacsmaryk in Amarillo, Texas, ordered a hold on federal approval of mifepristone, a drug approved by the U.S.
Texas mifepristone ruling undermines FDA approval process, experts say Read More »
The World Vaccine Congress 2023 convened in Washington, D.C., from April 3-6 to discuss a host of issues affecting vaccine uptake and infrastructure. Emily Acker,
World Vaccine Congress addresses vaccine hesitancy, infrastructure, policy Read More »
The threat of expanding intellectual property waivers by the World Trade Organization (WTO) dampens investment in research, Biotechnology Innovation Organization’s (BIO) Chief Policy Officer
BIO opposes extension of WTO IP waiver in federal hearing Read More »
The Council of State Bioscience Associations (CSBA), a coalition of state-based bioscience trade associations convened by the Biotechnology Innovation Organization (BIO), joined forces in
CSBA hits Capitol Hill for face time with lawmakers Read More »
The Accelerated Approval pathway was established by the U.S. Food and Drug Administration (FDA) in the 1990s to boost R&D for HIV/AIDS, and the
I am BIO Podcast: Accelerated Approval, accelerating hope Read More »
While awaiting for the public hearing on the proposed expansion of the COVID IP waiver that the U.S. International Trade Commission (USITC) has scheduled
IP waiver directly threatens U.S. medical innovation, biomanufacturing Read More »
The importance of data and the growing use of technology – such as wearables and other mobile devices and sensors that can collect and
How biotech is addressing sources of bias in studies using real-world evidence Read More »
In recent years, Artificial Intelligence (AI) has boomed in healthcare. AI is helping scientists obtain relevant data, accurately predict diseases at early stages, and
I am BIO Podcast: How AI and biotech can ‘run evolution at hyperspeed’ Read More »
